Rong Weining, Chen Xue, Zhao Kanxing, Liu Yani, Liu Xiaoxing, Ha Shaoping, Liu Wenzhou, Kang Xiaoli, Sheng Xunlun, Zhao Chen
Ningxia Eye Hospital, Ningxia People's Hospital, Ningxia, China.
Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, State Key Laboratory of Reproductive Medicine, Nanjing, China; Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China.
PLoS One. 2014 May 15;9(5):e97808. doi: 10.1371/journal.pone.0097808. eCollection 2014.
Usher syndrome (USH) is a group of disorders manifested as retinitis pigmentosa and bilateral sensorineural hearing loss, with or without vestibular dysfunction. Here, we recruited three Chinese families affected with autosomal recessive USH for detailed clinical evaluations and for mutation screening in the genes associated with inherited retinal diseases. Using targeted next-generation sequencing (NGS) approach, three new alleles and one known mutation in MYO7A gene were identified in the three families. In two families with USH type 1, novel homozygous frameshift variant p.Pro194Hisfs*13 and recurrent missense variant p.Thr165Met were demonstrated as the causative mutations respectively. Crystal structural analysis denoted that p.Thr165Met would very likely change the tertiary structure of the protein encoded by MYO7A. In another family affected with USH type 2, novel biallelic mutations in MYO7A, c.[1343+1G>A];[2837T>G] or p.[?];[Met946Arg], were identified with clinical significance. Because MYO7A, to our knowledge, has rarely been correlated with USH type 2, our findings therefore reveal distinguished clinical phenotypes associated with MYO7A. We also conclude that targeted NGS is an effective approach for genetic diagnosis for USH, which can further provide better understanding of genotype-phenotype relationship of the disease.
尤塞氏综合征(USH)是一组表现为色素性视网膜炎和双侧感音神经性听力损失的疾病,伴有或不伴有前庭功能障碍。在此,我们招募了三个患有常染色体隐性USH的中国家庭,进行详细的临床评估以及对与遗传性视网膜疾病相关的基因进行突变筛查。使用靶向二代测序(NGS)方法,在这三个家庭中鉴定出了MYO7A基因的三个新等位基因和一个已知突变。在两个1型USH家庭中,分别证实了新的纯合移码变体p.Pro194Hisfs*13和复发性错义变体p.Thr165Met为致病突变。晶体结构分析表明,p.Thr165Met很可能会改变由MYO7A编码的蛋白质的三级结构。在另一个2型USH家庭中,鉴定出了MYO7A的新的双等位基因突变,即c.[1343+1G>A];[2837T>G]或p.[?];[Met946Arg],具有临床意义。据我们所知,因为MYO7A很少与2型USH相关,所以我们的发现揭示了与MYO7A相关的独特临床表型。我们还得出结论,靶向NGS是USH基因诊断的一种有效方法,它可以进一步更好地理解该疾病的基因型-表型关系。